NDI Notification Draft Guidance In Brief
This article was originally published in The Tan Sheet
You may also be interested in...
GNC outperforming, issuing shares; Vitacost emerges from strategic review; Fleminger’s green tea QHC remanded back to FDA; supplement firm Modern Products unaware of GMPs; more news In Brief.
FDA issues guidance on splitting tablets